Skip to content

AtriCure

US · ATRC #2543 by market cap Listed 1970
55.39 +1.28 +2.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 54.05 -0.11%
After-hours 55.39 0.00%
65.5325.8655.392026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ATRC?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +41.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 9.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C

The radar needs all six factors. Available grades are shown below.

Valuation F

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 178.7x Better than 2%
Forward P/E 207.5x Better than 1%
Price / Sales 4.9x Better than 23%
P/E vs own 5-yr range 94th pctl Better than 10%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 75.0% Better than 87%
Operating margin -1.8% Better than 19%
Net margin -2.1% Better than 23%
Return on equity -2.4% Better than 25%
Return on invested capital -1.9% Better than 26%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 13.1% Better than 93%
6-month return 95.8% Better than 99%
12-month return (ex latest month) 63.0% Better than 88%
Distance below 52-week high 16.1% Better than 68%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.0x Better than 81%
Debt to assets 11.2% Better than 67%
Interest coverage -0.7x Better than 23%
Analyst View C+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 75.0% Better than 51%
Upside to average target 19.2% Better than 31%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -2.55%
1M -3.95%
3M +16.64%
6M +91.00%
YTD +40.02%
1Y +66.59%
3Y +32.07%
5Y -28.66%

Key statistics

Price & volume

Prev close
54.11
Open
54.03
Day range
54.03 - 56.19
Avg price
55.38
Volume
813.13K
Turnover
45.03M
Amplitude
3.99%
52-week range
25.36 - 66.02

Valuation

P/E
-230.79
P/E (TTM)
178.68
P/B
5.29
EPS
-0.24
Net profit
-12.22M
Net assets
533.21M

Share structure

Market cap
2.82B
Float cap
2.71B
Shares out
50.92M
Float shares
48.88M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 74% of range
25.36 66.02

16.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-23.42M net over the window

Short interest

Shares short
4.89M
As of
2026-10-30

Frequently asked questions

What is the current stock price of AtriCure (ATRC)?

AtriCure last traded at 55.39. This page shows a periodic quote snapshot. Check the displayed quote time.

What is AtriCure's market cap?

About 2.82B.

What is the P/E ratio of AtriCure?

The trailing twelve-month P/E is 178.68. The Valuation tab shows it against the stock's own five-year range.

Does AtriCure pay a dividend?

AtriCure does not currently pay a regular dividend.

Is AtriCure a buy according to analysts?

The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 66.00, which implies 19.2% upside from the current price. This is not investment advice.

What is AtriCure's StockVane Quant Rating?

The StockVane Momentum strategy currently rates AtriCure a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

AtriCure discussion 0 comments

Add a comment